These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 20446112

  • 1. Pre-exercise medium-chain triglyceride application prevents acylcarnitine accumulation in skeletal muscle from very-long-chain acyl-CoA-dehydrogenase-deficient mice.
    Primassin S, Tucci S, Herebian D, Seibt A, Hoffmann L, ter Veld F, Spiekerkoetter U.
    J Inherit Metab Dis; 2010 Jun; 33(3):237-46. PubMed ID: 20446112
    [Abstract] [Full Text] [Related]

  • 2. Medium-chain triglycerides impair lipid metabolism and induce hepatic steatosis in very long-chain acyl-CoA dehydrogenase (VLCAD)-deficient mice.
    Tucci S, Primassin S, Ter Veld F, Spiekerkoetter U.
    Mol Genet Metab; 2010 Sep; 101(1):40-7. PubMed ID: 20580297
    [Abstract] [Full Text] [Related]

  • 3. Corresponding increase in long-chain acyl-CoA and acylcarnitine after exercise in muscle from VLCAD mice.
    ter Veld F, Primassin S, Hoffmann L, Mayatepek E, Spiekerkoetter U.
    J Lipid Res; 2009 Aug; 50(8):1556-62. PubMed ID: 18980943
    [Abstract] [Full Text] [Related]

  • 4. Tissue-specific strategies of the very-long chain acyl-CoA dehydrogenase-deficient (VLCAD-/-) mouse to compensate a defective fatty acid β-oxidation.
    Tucci S, Herebian D, Sturm M, Seibt A, Spiekerkoetter U.
    PLoS One; 2012 Aug; 7(9):e45429. PubMed ID: 23024820
    [Abstract] [Full Text] [Related]

  • 5. Carnitine supplementation induces acylcarnitine production in tissues of very long-chain acyl-CoA dehydrogenase-deficient mice, without replenishing low free carnitine.
    Primassin S, Ter Veld F, Mayatepek E, Spiekerkoetter U.
    Pediatr Res; 2008 Jun; 63(6):632-7. PubMed ID: 18317232
    [Abstract] [Full Text] [Related]

  • 6. Sexual dimorphism of lipid metabolism in very long-chain acyl-CoA dehydrogenase deficient (VLCAD-/-) mice in response to medium-chain triglycerides (MCT).
    Tucci S, Flögel U, Spiekerkoetter U.
    Biochim Biophys Acta; 2015 Jul; 1852(7):1442-50. PubMed ID: 25887160
    [Abstract] [Full Text] [Related]

  • 7. Hepatic and muscular effects of different dietary fat content in VLCAD deficient mice.
    Primassin S, Tucci S, Spiekerkoetter U.
    Mol Genet Metab; 2011 Dec; 104(4):546-51. PubMed ID: 21963783
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tissue carnitine homeostasis in very-long-chain acyl-CoA dehydrogenase-deficient mice.
    Spiekerkoetter U, Tokunaga C, Wendel U, Mayatepek E, Ijlst L, Vaz FM, van Vlies N, Overmars H, Duran M, Wijburg FA, Wanders RJ, Strauss AW.
    Pediatr Res; 2005 Jun; 57(6):760-4. PubMed ID: 15774826
    [Abstract] [Full Text] [Related]

  • 10. Very long-chain acyl-CoA dehydrogenase (VLCAD-) deficiency-studies on treatment effects and long-term outcomes in mouse models.
    Tucci S.
    J Inherit Metab Dis; 2017 May; 40(3):317-323. PubMed ID: 28247148
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Changes in blood carnitine and acylcarnitine profiles of very long-chain acyl-CoA dehydrogenase-deficient mice subjected to stress.
    Spiekerkoetter U, Tokunaga C, Wendel U, Mayatepek E, Exil V, Duran M, Wijburg FA, Wanders RJ, Strauss AW.
    Eur J Clin Invest; 2004 Mar; 34(3):191-6. PubMed ID: 15025677
    [Abstract] [Full Text] [Related]

  • 16. The safety of Lipistart, a medium-chain triglyceride based formula, in the dietary treatment of long-chain fatty acid disorders: a phase I study.
    MacDonald A, Webster R, Whitlock M, Gerrard A, Daly A, Preece MA, Evans S, Ashmore C, Chakrapani A, Vijay S, Santra S.
    J Pediatr Endocrinol Metab; 2018 Mar 28; 31(3):297-304. PubMed ID: 29425111
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A heterozygous missense mutation in adolescent-onset very long-chain acyl-CoA dehydrogenase deficiency with exercise-induced rhabdomyolysis.
    Hisahara S, Matsushita T, Furuyama H, Tajima G, Shigematsu Y, Imai T, Shimohama S.
    Tohoku J Exp Med; 2015 Apr 28; 235(4):305-10. PubMed ID: 25843429
    [Abstract] [Full Text] [Related]

  • 19. The effect of fasting, long-chain triglyceride load and carnitine load on plasma long-chain acylcarnitine levels in mitochondrial very long-chain acyl-CoA dehydrogenase deficiency.
    Costa CG, Dorland L, de Almeida IT, Jakobs C, Duran M, Poll-The BT.
    J Inherit Metab Dis; 1998 Jun 28; 21(4):391-9. PubMed ID: 9700596
    [Abstract] [Full Text] [Related]

  • 20. Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse.
    Cox KB, Hamm DA, Millington DS, Matern D, Vockley J, Rinaldo P, Pinkert CA, Rhead WJ, Lindsey JR, Wood PA.
    Hum Mol Genet; 2001 Sep 15; 10(19):2069-77. PubMed ID: 11590124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.